STAT+: FDA expert committee reviews Capricor Therapeutics’ Duchenne drug

STAT News

STAT is live-blogging an FDA meeting on Capricor Therapeutics’ treatment for Duchenne muscular dystrophy, which has been the subject of a contentious regulatory review. ...

전문 보기

이 뉴스, 어떠셨어요?

탭 한 번으로 반응 · 로그인 불필요

관련 뉴스

관련 뉴스 제보는 로그인 후 가능합니다.

'science' 카테고리 뉴스

For veterans with severe PTSD, psilocybin-assisted therapy may help

Medical Xpress

The trillion-dollar question behind corporate net-zero pledges

Phys.org

Lanthanide carriers can enhance biomedical imaging and combined diagnosis and treatment approaches

Medical Xpress

STAT의 다른 기사

Opinion: U.S. dependence on China is a national security risk

STAT News

Opinion: Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases

STAT News

Is it safe to drink Red Bull and vodka? Questionable research tied to energy drink giant has shaped policy

STAT News